Thu, February 10, 2022
Wed, February 9, 2022
Tue, February 8, 2022

Sarah James Maintained (THC) at Buy with Increased Target to $99 on, Feb 9th, 2022

Sarah James of Barclays, Maintained "Tenet Healthcare Corporation" (THC) at Buy with Increased Target from $87 to $99 on, Feb 9th, 2022.

Sarah has made no other calls on THC in the last 4 months.



There are 5 other peers that have a rating on THC. Out of the 5 peers that are also analyzing THC, 1 agrees with Sarah's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $92 on, Tuesday, November 9th, 2021


These are the ratings of the 4 analyists that currently disagree with Sarah


  • John Ransom of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $120 on, Thursday, January 20th, 2022
  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $90 on, Wednesday, November 10th, 2021
  • Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Monday, October 25th, 2021
  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Friday, October 22nd, 2021